You are on page 1of 9

1. Gilbert WM, Nesbitt TS, Danielsen B.

Childbearing beyond age 40: pregnancy outcome in 24,032 cases.


Obstet Gynecol 1999;93:9-14.
2. Hayward CE, Greenwood SL, Sibley CP, Baker PN, Challis JR, Jones
RL.
Effect of maternal age and growth on placental nutrient transport: potential
mechanisms for teenagers' predisposition to small-for-gestational-age birth?
Am J Physiol Endocrinol Metab 2012;302:E233-42.
3. Nohuz E, Rivière O, Coste K, Vendittelli F.
Prenatal identification of small-for-gestational age and risk of neonatal
morbidity and stillbirth.
Ultrasound Obstet Gynecol 2020;55:621-8.
4. Parker JD, Schoendorf KC, Kiely JL.
Associations between measures of socioeconomic status and low birth
weight, small for gestational age, and premature delivery in the United
States.
Ann Epidemiol 1994;4:271-8.
5. Nizard J.
Prévention du RCIU vasculaire.
J Gynecol Obstet Biol Reprod (Paris) 2013;42:1008-17.
6. Vega J, Sáez G, Smith M, Agurto M, Morris NM.
Risk factors for low birth weight and intrauterine growth retardation in
Santiago, Chile.
Rev Med Chil 1993;121:1210-9.
7. Tietche F, Ngoufack G, Kago I, Mbonda E, Koki Ndombo PO, Leke RI.
Facteurs étiologiques associés au retard de croissance intra-utérin à Yaoundé
(Cameroun): étude préliminaire.
Med Afr Noire 1998;45:377-80.
8. Yadav DK, Shukla GS, Gupta N, Shrestha N, Singh A, Kaphle HP.
Maternal and obstetric factors associated with low birth weight.
J Nepal Health Res Counc 2020;17:443-50.
9. Kramer MS.
Determinants of low birth weight: methodological assessment and meta-
analysis.
Bull World Health Organ 1987;65:663-737.
10. Allen VM, Joseph K, Murphy KE, Magee LA, Ohlsson A.
The effect of hypertensive disorders in pregnancy on small for gestational
age and stillbirth: a population based study.
BMC Pregnancy Childbirth 2004;4:17.
11. Wikström AK, Gunnarsdottir J, Nelander M, Simic M, Stephansson O,
Cnattingius S.
Prehypertension in Pregnancy and Risks of Small for Gestational Age Infant
and Stillbirth.
Hypertension 2016;67:640-6.
12. Wikström AK, Gunnarsdottir J, Nelander M, Simic M, Stephansson O,
Cnattingius S.
Prehypertension in Pregnancy and Risks of Small for Gestational Age Infant
and Stillbirth.
Hypertension 2016;67:640-6.
13. Macdonald-Wallis C, Tilling K, Fraser A, Nelson SM, Lawlor DA.
Associations of blood pressure change in pregnancy with fetal growth and
gestational age at delivery: findings from a prospective cohort.
Hypertension 2014;64:36-44.
14. Fedrick J, Adelstein P.
Factors associated with low birth weight of infants delivered at term.
Br J Obstet Gynaecol 1978;85:1-7.
15. Awuah SP, Okai I, Ntim EA, Bedu-Addo K.
Prevalence, placenta development, and perinatal outcomes of women with
hypertensive disorders of pregnancy at Komfo Anokye Teaching Hospital.
PLoS One 2020;15:e0233817.
16. Kemppinen L, Mattila M, Ekholm E, Pallasmaa N, Törmä A, Varakas
L, et al.
Gestational iron deficiency anemia is associated with preterm birth, fetal
growth restriction, and postpartum infections.
J Perinat Med 2020;49:431-8.
17. Ronnenberg AG, Wood RJ, Wang X, Xing H, Chen C, Chen D, et al.
Preconception hemoglobin and ferritin concentrations are associated with
pregnancy outcome in a prospective cohort of Chinese women.
J Nutr 2004;134:2586-91.
18. Yamamoto R, Ishii K, Shimada M, Hayashi S, Hidaka N, Nakayama M,
et al.
Significance of maternal screening for toxoplasmosis, rubella,
cytomegalovirus and herpes simplex virus infection in cases of fetal growth
restriction.
J Obstet Gynaecol Res. 2013;39:653-7.
19. Cordier AG, Nedellec S, Benachi A, Frydman R, Picone O.
Quels arguments pour déterminer l'origine infectieuse d'un retard de
croissance intra-utérin?
J Gynecol Obstet Biol Reprod (Paris) 2011;40:109-15.
20. Macé G, Gallot V, Vauloup-Fellous C, Picone O.
Varicelle pendant la grossesse: mise au point.
J Gynecol Obstet Biol Reprod (Paris) 2008;37:22-8.
21. Chabchoub I, Mejdoub I, Maalej B, Abid D, Aloulou H, Kamoun T, et
al.
La rubéole congénitale existe encore en Tunisie!
Arch Pediatr 2011;18:1191-5.
22. Baschat AA.
Planning management and delivery of the growth-restricted fetus.
Best Pract Res Clin Obstet Gynaecol 2018;49:53-65.
23. Cosmi E, Ambrosini G, D'Antona D, Saccardi C, Mari G.
Doppler, cardiotocography, and biophysical profile changes in growth-
restricted fetuses.
Obstet Gynecol. 2005;106:1240-5.
24. Hecher K, Bilardo CM, Stigter RH, Ville Y, Hackelöer BJ, Kok HJ, et
al.
Monitoring of fetuses with intrauterine growth restriction: a longitudinal
study.
Ultrasound Obstet Gynecol 2001;18:564-70.
25. Baschat AA, Gembruch U, Harman CR.
The sequence of changes in Doppler and biophysical parameters as severe
fetal growth restriction worsens.
Ultrasound Obstet Gynecol 2001;18:571-7.
26. Saliba M, Bourcy E, Lapotre T, Gkiougki E, Kefala K, Nyamugabo
Munyere Nkana K, et al.
A propos du retard de croissance intra-utérin.
Bruxelles: Journées Annuelles de la Société Belge de Pédiatrie; 2014.
27. Figueras F, Gratacós E.
Update on the diagnosis and classification of fetal growth restriction and
proposal of a stage-based management protocol.
Fetal Diagn Ther 2014;36:86-98.
28. Chan FY, Pun TC, Lam C, Khoo J, Lee CP, Lam YH.
Pregnancy screening by uterine artery Doppler velocimetry - Which criterion
performs best?
Obstet Gynecol 1995;85:596-602.
29. Sciscione AC, Hayes EJ.
Uterine artery Doppler flow studies in obstetric practice.
Am J Obstet Gynecol 2009;201:121-6.
30. Horowitz KM, Feldman D.
Fetal growth restriction: risk factors for unplanned primary cesarean
delivery.
J Matern Fetal Neonatal Med 2015;28:2131-4.
31. Lambert G, Brichant JF, Hartstein G, Bonhomme V, Dewandre PY.
Preeclampsia: an update.
Acta Anaesthesiol Belg. 2014;65:137-49.
32. Proctor LK, Kfouri J, Hiersch L, Aviram A, Zaltz A, Kingdom J, et al.
Association between hypertensive disorders and fetal growth restriction in
twin compared with singleton gestations.
Am J Obstet Gynecol 2019;221:251.
33. Redline RW, O'Riordan MA.
Placental lesions associated with cerebral palsy and neurologic impairment
following term birth.
Arch Pathol Lab Med 2000;124:1785-91.
34. L’Herminé-Coulomb A.
Examen du placenta.
EMC - Obstétrique [Article n°5-070-C-20] 2006;1:1-15. 
35. Sheppard BL, Bonnar J.
Uteroplacental hemostasis in intrauterine fetal growth retardation.
Semin Thromb Hemost 1999;25:443-6.
36. Visser GH, Redman CW, Huisjes HJ, Turnbull AC.
Nonstressed antepartum heart rate monitoring: implications of decelerations
after spontaneous contractions.
Am J Obstet Gynecol 1980;138:429-35.
37. Philippe E.
Pathologie foeto-placentaire.
Paris: Elsevier Masson; 1986. 
38. Roberts DJ, Post MD.
The placenta in pre-eclampsia and intrauterine growth restriction.
J Clin Pathol 2008;61:1254-60.
39. Zaidi H, Lamalmi N, Malihi A, Barkat A, Alhamany Z.
Les lésions histopathologiques du placenta au cours de retard de croissance
intra utérine sévère: à propos d'un cas clinique.
Pan Afr Med J 2019;34:56.
40. Marcorelles P.
L'examen du placenta dans le retard de croissance intra-utérin.
J Gynecol Obstet Biol Reprod (Paris) 2013;42:996-1007.
41. Ogino S, Redline RW.
Villous capillary lesions of the placenta: distinctions between chorangioma,
chorangiomatosis, and chorangiosis.
Hum Pathol 2000;31:945-54.
42. Yelnik C, Lambert M, Le Guern V, Bacri JL, Guerrra MM, Morel N, et
al.
Bénéfice et risque du traitement antithrombotique au cours de 264 grossesses
évolutives chez des patientes atteintes d’un syndrome des
antiphospholipides.
Rev Med Interne 2016;37:A130.
43. Katzman PJ, Genest DR.
Maternal floor infarction and massive perivillous fibrin deposition:
histological definitions, association with intrauterine fetal growth restriction,
and risk of recurrence.
Pediatr Dev Pathol 2002;5:159-64.
44. Naeye RL.
Maternal floor infarction.
Hum Pathol 1985;16:823-8.
45. Bernstein PS, Divon MY.
Etiologies of fetal growth restriction.
Clin Obstet Gynecol 1997;40:723-9.
46. Chen CP, Chern SR, Lee CC, Town DD.
Isochromosome 18q in a fetus with congenital megacystis, intra-uterine
growth retardation and cloacal dysgenesis sequence.
Prenat Diagn 1998;18:1068-74.
47. Redline RW, Faye-Petersen O, Heller D, Qureshi F, Savell V, Vogler Cet
al.
Amniotic infection syndrome: nosology and reproducibility of placental
reaction patterns.
Pediatr Dev Pathol 2003;6:435-48.
48. Moyambe JN, Bernard P, Khang'Mate F, Nkoy AM, Mukalenge FC,
Makanda D, et al.
Etude des facteurs de risque du retard de croissance intra-utérin à
Lubumbashi.
Pan Afr Med J 2013;14:4.
49. Jacques SM, Qureshi F.
Chronic chorioamnionitis: a clinicopathologic and immunohistochemical
study.
Hum Pathol 1998;29:1457-61.
50. Amer HZ, Heller DS.
Chorangioma and related vascular lesions of the placenta - a review.
Fetal Pediatr Pathol 2010;29:199-206.
51. Cravageot B.
L’insertion vélamenteuse du cordon: quand le fil de la vie devient anomalie
[Mémoire].
Nanacy: Université Henri Poincaré, École de Sages-femmes Albert
Fruhinsholz; 2010.
52. Räisänen S, Georgiadis L, Harju M, Keski-Nisula L, Heinonen S.
Risk factors and adverse pregnancy outcomes among births affected by
velamentous umbilical cord insertion: a retrospective population-based
register study.
Eur J Obstet Gynecol Reprod Biol 2012;165:231-4.
53. Chard T, Yoong A, Macintosh M.
The myth of fetal growth retardation at term.
Br J Obstet Gynaecol 1993;100:1076-81.
54. Sun C, Groom KM, Oyston C, Chamley LW, Clark AR, James JL.
The placenta in fetal growth restriction: What is going wrong?
Placenta 2020;96:10-8.
55. Jeanpierre M.
Gènes et retards de croissance intra-utérins.
Arch Pediatr 1998;5:332S-7.

You might also like